Safety of sugammadex for myasthaenia gravis patients undergoing general anaesthesia: a retrospective database study

BACKGROUND: Using neuromuscular blocking drugs (NMBDs) for patients with myasthaenia gravis remains a challenge in perioperative management. Sugammadex has enabled the safe use of NMBDs. We investigated whether the adverse outcomes, and the treatment used for myasthaenic crises and tracheotomy, are...

Descripción completa

Detalles Bibliográficos
Autores principales: Nahara, Isao, Takeuchi, Masato, Yonekura, Hiroshi, Takeda, Chikashi, Kawakami, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430823/
https://www.ncbi.nlm.nih.gov/pubmed/37588779
http://dx.doi.org/10.1016/j.bjao.2022.100092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430823/
https://www.ncbi.nlm.nih.gov/pubmed/37588779
http://dx.doi.org/10.1016/j.bjao.2022.100092

Ejemplares similares